Oral Administration of Nicotinamide Mononucleotide with Bioenhancer BioPerine？ Increases the Serum Concentration of Nicotinamide Adenine Dinucleotide in Healthy Human Volunteers: A Pilot, Open-Label, Cross-Over Study
Background: Bioenhancers augment the bioavailability of co-administered molecules without showing any significant effect on their own. Piperine, an alkaloid from Piper nigrum, is an established natural bioenhancer. Nicotinamide mononucleotide (NMN), an antiaging supplement, is the precursor of coenzyme nicotinamide adenine dinucleotide (NAD) that plays an important role in intracellular redox reactions. Objective: The study compared the serum concentrations of NAD in normal healthy participants, supplemented with NMN 500 mg and NMN 500 mg + 5 mg BioPerine？ (95% piperine). Methods: In a randomized, open-label, crossover study, NMN (500 mg) was compared to NMN + BioPerine？ (500 mg + 5 mg) in 6 healthy adults, aged 18 - 45 years. The participants received a single oral dose of NMN or NMN + BioPerine？ capsules with 240 mL water, and blood samples were collected over 8hr. After a 4-day washout period, the same procedures were repeated as per the crossover design. Total NAD (NADtotal), including oxidized NAD (the oxidized) and its reduced form NADH, was measured in human serum samples. Results: The maximum concentration (Cmax) of NAD in serum was higher with NMN + BioPerine？ (282 pmol/mL) compared to NMN (246 pmol/mL) alone. In the presence of BioPerine？, the NAD concentrations reached 257 pmol/mL during the first 2 hr, whereas a comparable serum concentration (246 pmol/mL) was attained only after 6 hr in NMN alone. The AUC0-8hr was 1738 pmol/mL/hr in NMN compared to 2004 pmol/mL/hr in NMN+ BioPerine？. The time to reach peak concentration (t1/2) was similar (6hr) in both groups. No clinically relevant adverse events (AE) were observed, and safety parameters remained within normal ranges in all the participants with both formulations. Conclusion: These results reveal that BioPerine？ can effectively increase the NAD concentrations in the serum following NMN supplementation in healthy volunteers. The present study was registered prospectively with the Clinical Trials Registry-India (CTRI/2023/11/059982).
References
[1]
Srinivasan, K. (2007) Black Pepper and Its Pungent Principle-Piperine: A Review of Diverse Physiological Effects. CriticalReviewsinFoodScienceandNutrition, 47, 735-748. https://doi.org/10.1080/10408390601062054
[2]
McReynolds, M.R., Chellappa, K. and Baur, J.A. (2020) Age-Related NAD+ Decline. ExperimentalGerontology, 134, Article ID: 110888. https://doi.org/10.1016/j.exger.2020.110888
[3]
Azam, S., Park, J., Kim, I. and Choi, D. (2022) Piperine and Its Metabolite’s Pharmacology in Neurodegenerative and Neurological Diseases. Biomedicines, 10, Article 154. https://doi.org/10.3390/biomedicines10010154
[4]
Meghwal, M. and Goswami, T.K. (2013) Pipernigrum and Piperine: An Update. PhytotherapyResearch, 27, 1121-1130. https://doi.org/10.1002/ptr.4972
[5]
Randhawa, G., Kullar, J. and Rajkumar, (2011) Bioenhancers from Mother Nature and Their Applicability in Modern Medicine. InternationalJournalofAppliedandBasicMedicalResearch, 1, 5-10. https://doi.org/10.4103/2229-516x.81972
[6]
Atal, N. and Bedi, K. (2010) Bioenhancers: Revolutionary Concept to Market. JournalofAyurvedaandIntegrativeMedicine, 1, 96-99. https://doi.org/10.4103/0975-9476.65073
[7]
Singh, S., Tripathi, J. and Rai, N. (2016) An Appraisal of the Bioavailability Enhancers in Ayurveda in the Light of Recent Pharmacological Advances. AYU (AnInternationalQuarterlyJournalofResearchinAyurveda), 37, 3-10. https://doi.org/10.4103/ayu.ayu_11_15
[8]
Atal, C. (1979) A Breakthrough in Drug Bioavailability—A Clue from Age Old Wisdom of Ayurveda. IDMA Bulletin, 10, 483-484.
[9]
Bhardwaj, R.K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S.K. and Fromm, M.F. (2002) Piperine, a Major Constituent of Black Pepper, Inhibits Human P-Glycoprotein and Cyp3a4. JournalofPharmacologyandExperimentalTherapeutics, 302, 645-650. https://doi.org/10.1124/jpet.102.034728
[10]
Atal, C., Dubey, R.K. and Singh, J. (1985) Biochemical Basis of Enhanced Drug Bioavailability by Piperine: Evidence That Piperine Is a Potent Inhibitor of Drug Metabolism. Journal of Pharmacology and Experimental Therapeutics, 232, 258-262.
[11]
Dudhatra, G.B., Mody, S.K., Awale, M.M., Patel, H.B., Modi, C.M., Kumar, A., et al. (2012) A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers. TheScientificWorldJournal, 2012, Article ID: 637953. https://doi.org/10.1100/2012/637953
[12]
Johri, R.K., Thusu, N., Khajuria, A. and Zutshi, U. (1992) Piperine-Mediated Changes in the Permeability of Rat Intestinal Epithelial Cells. BiochemicalPharmacology, 43, 1401-1407. https://doi.org/10.1016/0006-2952(92)90195-o
[13]
Kesarwani, K. and Gupta, R. (2013) Bioavailability Enhancers of Herbal Origin: An Overview. AsianPacificJournalofTropicalBiomedicine, 3, 253-266. https://doi.org/10.1016/s2221-1691(13)60060-x
[14]
Shade, C. (2020) The Science behind NMN-A Stable, Reliable NAD+ Activator and Anti-Aging Molecule. Integrative Medicine, 19, 12-14.
[15]
Tokizane, K. and Imai, S. (2021) NAD+ Oscillation and Hypothalamic Neuronal Functions. FacultyReviews, 10, 42. https://doi.org/10.12703/r/10-42
[16]
Hideshima, T. and Nishimura, M. (2022) Nicotinamide Adenine Dinucleotide and Adenosine Triphosphate Oscillations Caused by Gradual Entry of Substrates within Mitochondria. JournalofBiophysicalChemistry, 13, 13-28. https://doi.org/10.4236/jbpc.2022.132002
[17]
Niccoli, T. and Partridge, L. (2012) Ageing as a Risk Factor for Disease. CurrentBiology, 22, R741-R752. https://doi.org/10.1016/j.cub.2012.07.024
[18]
Imai, S. and Guarente, L. (2014) NAD+ and Sirtuins in Aging and Disease. TrendsinCellBiology, 24, 464-471. https://doi.org/10.1016/j.tcb.2014.04.002
[19]
Covarrubias, A.J., Perrone, R., Grozio, A. and Verdin, E. (2020) NAD+ Metabolism and Its Roles in Cellular Processes during Ageing. NatureReviewsMolecularCellBiology, 22, 119-141. https://doi.org/10.1038/s41580-020-00313-x
[20]
Camacho-Pereira, J., Tarragó, M.G., Chini, C.C.S., Nin, V., Escande, C., Warner, G.M., et al. (2016) CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an Sirt3-Dependent Mechanism. CellMetabolism, 23, 1127-1139. https://doi.org/10.1016/j.cmet.2016.05.006
[21]
López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The Hallmarks of Aging. Cell, 153, 1194-1217. https://doi.org/10.1016/j.cell.2013.05.039
[22]
Diamanti-Kandarakis, E., Dattilo, M., Macut, D., Duntas, L., Gonos, E.S., Goulis, D.G., et al. (2017) Mechanisms in Endocrinology: Aging and Anti-Aging: A Combo-Endocrinology Overview. EuropeanJournalofEndocrinology, 176, R283-R308. https://doi.org/10.1530/eje-16-1061
[23]
Nadeeshani, H., Li, J., Ying, T., Zhang, B. and Lu, J. (2022) Nicotinamide Mononucleotide (NMN) as an Anti-Aging Health Product—Promises and Safety Concerns. JournalofAdvancedResearch, 37, 267-278. https://doi.org/10.1016/j.jare.2021.08.003
[24]
Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S. and Sadoshima, J. (2014) Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion. PLOSONE, 9, e98972. https://doi.org/10.1371/journal.pone.0098972
Yi, L., Maier, A.B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., et al. (2022) The Efficacy and Safety of Β-Nicotinamide Mononucleotide (NMN) Supplementation in Healthy Middle-Aged Adults: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Dependent Clinical Trial. GeroScience, 45, 29-43. https://doi.org/10.1007/s11357-022-00705-1
[27]
Bai, L., Yau, L., Tong, T., Chan, W., Zhang, W. and Jiang, Z. (2022) Improvement of Tissue-Specific Distribution and Biotransformation Potential of Nicotinamide Mononucleotide in Combination with Ginsenosides or Resveratrol. PharmacologyResearch&Perspectives, 10, e00986. https://doi.org/10.1002/prp2.986
[28]
Sabbagh, F. and Kim, B. (2023) ExVivo Transdermal Delivery of Nicotinamide Mononucleotide Using Polyvinyl Alcohol Microneedles. Polymers, 15, Article 2031. https://doi.org/10.3390/polym15092031
[29]
Igarashi, M., Nakagawa-Nagahama, Y., Miura, M., Kashiwabara, K., Yaku, K., Sawada, M., et al. (2022) Chronic Nicotinamide Mononucleotide Supplementation Elevates Blood Nicotinamide Adenine Dinucleotide Levels and Alters Muscle Function in Healthy Older Men. NPJAging, 8, Article No. 5. https://doi.org/10.1038/s41514-022-00084-z
[30]
Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., et al. (2020) Effect of Oral Administration of Nicotinamide Mononucleotide on Clinical Parameters and Nicotinamide Metabolite Levels in Healthy Japanese Men. EndocrineJournal, 67, 153-160. https://doi.org/10.1507/endocrj.ej19-0313
[31]
Okabe, K., Yaku, K., Uchida, Y., Fukamizu, Y., Sato, T., Sakurai, T., et al. (2022) Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. FrontiersinNutrition, 9, Article 868640. https://doi.org/10.3389/fnut.2022.868640
[32]
Ultra Nutrio (2023) Piperine: What Is It, Benefits, Side Effects, Dosage, and More.
[33]
Khajuria, A., Thusu, N. and Zutshi, U. (2002) Piperine Modulates Permeability Characteristics of Intestine by Inducing Alterations in Membrane Dynamics: Influence on Brush Border Membrane Fluidity, Ultrastructure and Enzyme Kinetics. Phytomedicine, 9, 224-231. https://doi.org/10.1078/0944-7113-00114
[34]
Tatiraju, D.V., Bagade, V.B., Karambelkar, P.J., Jadhav, V.M. and Kadam, V. (2013) Natural Bioenhancers: An Overview. JournalofPharmacognosyandPhytochemistry, 2, 55-60.
[35]
Badmaev, V., Majeed, M. and Prakash, L. (2000) Piperine Derived from Black Pepper Increases the Plasma Levels of Coenzyme Q10 Following Oral Supplementation. TheJournalofNutritionalBiochemistry, 11, 109-113. https://doi.org/10.1016/s0955-2863(99)00074-1
[36]
Badmaev, V., Majeed, M. and Norkus, E.P. (1999) Piperine, an Alkaloid Derived from Black Pepper Increases Serum Response of Beta-Carotene during 14-Days of Oral β-Carotene Supplementation. NutritionResearch, 19, 381-388. https://doi.org/10.1016/s0271-5317(99)00007-x
[37]
Zeng, X., Cai, D., Zeng, Q., Chen, Z., Zhong, G., Zhuo, J., et al. (2017) Selective Reduction in the Expression of Ugts and Sults, a Novel Mechanism by Which Piperine Enhances the Bioavailability of Curcumin in Rat. Biopharmaceutics&DrugDisposition, 38, 3-19. https://doi.org/10.1002/bdd.2049
[38]
Lee, S.H., Kim, H.Y., Back, S.Y. and Han, H. (2017) Piperine-mediated Drug Interactions and Formulation Strategy for Piperine: Recent Advances and Future Perspectives. ExpertOpiniononDrugMetabolism&Toxicology, 14, 43-57. https://doi.org/10.1080/17425255.2018.1418854
[39]
Chaudhri, S.K. and Jain, S. (2023) A Systematic Review of Piperine as a Bioavailability Enhancer. Journal of Drug Delivery and Therapeutics, 13, 133-136. https://doi.org/10.22270/jddt.v13i4.5781
[40]
Shaikh, J., Ankola, D.D., Beniwal, V., Singh, D. and Kumar, M.N.V.R. (2009) Nanoparticle Encapsulation Improves Oral Bioavailability of Curcumin by at Least 9-Fold When Compared to Curcumin Administered with Piperine as Absorption Enhancer. EuropeanJournalofPharmaceuticalSciences, 37, 223-230. https://doi.org/10.1016/j.ejps.2009.02.019
[41]
Johri, R.K. and Zutshi, U. (1992) An Ayurvedic Formulation ‘Trikatu’ and Its Constituents. JournalofEthnopharmacology, 37, 85-91. https://doi.org/10.1016/0378-8741(92)90067-2
[42]
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J. and Nowaczyk, A. (2023) The Bioavailability of Drugs—The Current State of Knowledge. Molecules, 28, 8038. https://doi.org/10.3390/molecules28248038
[43]
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R. and Srinivas, P. (1998) Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers. PlantaMedica, 64, 353-356. https://doi.org/10.1055/s-2006-957450
[44]
Majeed, M., Bani, S., Pandey, A., Ansari, M. and Thazhathidath, S. (2023) Evaluation of Pharmacokinetic Profile of Cirpusins®, Extract of Cyperusrotundus in Presence of Bioavailability Enhancer, Bioperine®. JournalofAppliedBiotechnology, 1, 1-14. https://doi.org/10.5296/jab.v10i1.20594
[45]
Majeed, M., Vaidyanathan, P., Kiradi, P., Majeed, S. and Vuppala, K.K. (2016) An Evaluation of Bioavailability Enhancement of Organic Elemental Iron with BioPerine® in Rabbits. International Journal of Pharmacology and Pharmaceutical Research, 5, 72-79.
[46]
Jin, Z., Qiu, W., Liu, H., Jiang, X. and Wang, L. (2018) Enhancement of Oral Bioavailability and Immune Response of Ginsenoside Rh2 by Co-Administration with Piperine. ChineseJournalofNaturalMedicines, 16, 143-149. https://doi.org/10.1016/s1875-5364(18)30041-4
[47]
Di, X., Wang, X., Di, X. and Liu, Y. (2015) Effect of Piperine on the Bioavailability and Pharmacokinetics of Emodin in Rats. JournalofPharmaceuticalandBiomedicalAnalysis, 115, 144-149. https://doi.org/10.1016/j.jpba.2015.06.027
[48]
Zhang, W., Zheng, Q., Song, M., Xiao, J., Cao, Y., Huang, Q., et al. (2021) A Review on the Bioavailability, Bio-Efficacies and Novel Delivery Systems for Piperine. Food&Function, 12, 8867-8881. https://doi.org/10.1039/d1fo01971f
[49]
Benjamin, C. and Crews, R. (2024) Nicotinamide Mononucleotide Supplementation: Understanding Metabolic Variability and Clinical Implications. Metabolites, 14, Article 341. https://doi.org/10.3390/metabo14060341
[50]
Wang, P., Chen, M., Hou, Y., Luan, J., Liu, R., Chen, L., et al. (2023) Fingerstick Blood Assay Maps Real-World NAD+ Disparity across Gender and Age. AgingCell, 22, e13965. https://doi.org/10.1111/acel.13965
[51]
Yang, L., Shen, J., Liu, C., Kuang, Z., Tang, Y., Qian, Z., et al. (2023) Nicotine Rebalances NAD+ Homeostasis and Improves Aging-Related Symptoms in Male Mice by Enhancing NAMPT Activity. NatureCommunications, 14, Article No. 900. https://doi.org/10.1038/s41467-023-36543-8
